Taking into account the results published in BRAF mutated melanomas, though unproved on thyroid PTCs, BRAF inhibition also stimulates some gene programs such as oxidative phosphorylation, mitochondrial mechanisms, and the levels of PGC1α [67-71, 74]. Here, BRAF is linked to melanoma.